Marlene Wewalka

Dr. Marlene Wewalka


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2012 in Critical Care
Verified
Journal Article
Open access
PDF file
AFAndreas S Fazekas
Andreas S Fazekas
MWMarlene Wewalka
Marlene Wewalka
CZChristian Zauner
Christian Zauner
GFGeorg-Christian Funk
Georg-Christian Funk
Introduction: Critical illness leads to increased endogenous production of carbon monoxide (CO) due to the induction of the stress-response enzyme, heme oxygenase-1 (HO-1). There is evidence for the cytoprotective and anti-inflammatory effects of CO based on animal studies. In critically ill patients after cardiothoracic surgery, low minimum and high maximum carboxyhemoglobin (COHb) levels were shown to be associated with increased mortality, which suggests that there is an 'optimal range' for HO-1 activity. Our study aimed to test whether this relationship between COHb and outcome exists in non-surgical ICU patients. Methods: We conducted a retrospective, observational study in a medical ICU at a university hospital in Vienna, Austria involving 868 critically ill patients. No interventions were undertaken. Arterial COHb was measured on admission and during the course of treatment in the ICU. The association between arterial COHb levels and ICU mortality was evaluated using bivariate tests and a logistic regression model. Results: Minimum COHb levels were slightly lower in non-survivors compared to survivors (0.9%, 0.7% to 1.2% versus 1.2%, 0.9% to 1.5%; P = 0.0001), and the average COHb levels were marginally lower in non-survivors compared to survivors (1.5%, 1.2% to 1.8% versus 1.6%, 1.4% to 1.9%, P = 0.003). The multivariate logistic regression analysis revealed that the association between a low minimum COHb level and increased mortality was independent of the severity of illness and the type of organ failure. Conclusions: Critically ill patients surviving the admission to a medical ICU had slightly higher minimum and marginally higher average COHb levels when compared to non-survivors. Even though the observed differences are statistically significant, the minute margins would not qualify COHb as a predictive marker for ICU mortality.

22 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMathias Schneeweiss-Gleixner
Mathias Schneeweiss-Gleixner
PHPatrick Haselwanter
Patrick Haselwanter
BSBruno Schneeweiss
Bruno Schneeweiss
CZChristian Zauner
Christian Zauner
MWMarlene Wewalka
Marlene Wewalka
Refeeding syndrome (RFS) is a potentially life-threatening complication in malnourished (critically ill) patients. The presence of various accepted RFS definitions and the inclusion of heterogeneous patient populations in the literature has led to discrepancies in reported incidence rates in patients requiring treatment at an intensive care unit (ICU). We conducted a prospective observational study from 2010 to 2013 to assess the RFS incidence and clinical characteristics among medical ICU patients at a large tertiary center. RFS was defined as a decrease of more than 0.16 mmol/L serum phosphate to values below 0.65 mmol/L within seven days after the start of medical nutrition therapy or pre-existing serum phosphate levels below 0.65 mmol/L. Overall, 195 medical patients admitted to the ICU were included. RFS was recorded in 92 patients (47.18%). The presence of RFS indicated significantly altered phosphate and potassium levels and was accompanied by significantly more electrolyte substitutions (phosphate, potassium, and magnesium). No differences in fluid balance, energy delivery, and insulin requirements were detected. The presence of RFS had no impact on ICU length of stay and ICU mortality. Screening for RFS using simple diagnostic criteria based on serum phosphate levels identified critically ill patients with an increased demand for electrolyte substitutions. Therefore, stringent monitoring of electrolyte levels is indicated to prevent life-threatening complications.

19 February 2018 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
MWMarlene Wewalka
Marlene Wewalka
ADAndreas Drolz
Andreas Drolz
BSBerit Seeland
Berit Seeland
MSMathias Schneeweiss
Mathias Schneeweiss
MSMonika Schmid
Monika Schmid
CZChristian Zauner
Christian Zauner

31 March 2016 in Journal of Nephropathology
Verified
Journal Article
Open access
DNDashurie Neziri
Dashurie Neziri
SPSahra Pajenda
Sahra Pajenda
RARebecca Amuge
Rebecca Amuge
AIAysegul Ilhan
Aysegul Ilhan
MWMarlene Wewalka
Marlene Wewalka
LWLudwig Wagner
Ludwig Wagner
DDRGK1 in urine indicative of tubular cell injury in intensive care patients with serious infections

11 April 2022 in Nutrition
Verified
Journal Article
Closed access
MWMarlene Wewalka
Marlene Wewalka
MSMathias Schneeweiss
Mathias Schneeweiss
PHPatrick Haselwanter
Patrick Haselwanter
BSBruno Schneeweiss
Bruno Schneeweiss
CZChristian Zauner
Christian Zauner